[K. Vermani and S. Garg, The scope and potential of vaginal drug delivery, PSTT, 3 (2000) 359-364; DOI: S1461-5347(00)00296-0.10.1016/S1461-5347(00)00296-0]Search in Google Scholar
[P. Colombo, U. Conte and A. Gazzaniga, Drug release modulation by physical restrictions of matrix swelling, Int. J. Pharm. 63 (1990) 43-48; DOI: 10.1016/0378-5173(90)90099-P.10.1016/0378-5173(90)90099-P]Search in Google Scholar
[Y. Qiu, N. Chidambaram and K. Flood, Design and evaluation of layered diffusional matrices for zero-order sustained release, J. Control. Rel. 51 (1998) 123-130; DOI: PII S0168-3659(97)00119-3.10.1016/S0168-3659(97)00119-3]Search in Google Scholar
[N. Chidambaram, W. Porter, K. Flood and Y. Qui, Formulation and characterization of new layered diffusional matrices for zero-order sustained release, J. Control. Rel. 52 (1998) 149-158; DOI: 10.1016/S0168-3659(97)00207-1.10.1016/S0168-3659(97)00207-1]Search in Google Scholar
[U. Conte and L. Maggi, A flexible technology for the linear, pulsative and delayed release drugs, allowing for easy accommodation of difficult in vitro targets, J. Control. Rel. 64 (2000) 263-268; DOI: 10.1016/S0168-3659(99)00147-9.10.1016/S0168-3659(99)00147-9]Search in Google Scholar
[N. M. Zakia, G. A. Awada, N. D. Mortadaa, S. Seham and A. E. Hady, Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties, Eur. J. Pharm. Sci. 3 (2007) 296-307; DOI: 10.1016/j.ejps.2007.08.006.10.1016/j.ejps.2007.08.006]Search in Google Scholar
[S. Lybak, E. Kjellen, P. Nilsson, A. Tomaszewicz, J. Wennerberg and R. W. Pero, Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation, Acta Oncol. 31 (1992) 469-474.10.3109/02841869209088291]Search in Google Scholar
[J. Wennerberg, E. Kjellen, S. Lybak, R. Rydell and R. Pero, Biochemical modulation of chemotherapy and radiotherapy in head and neck cancer, Anticancer Res. 13 (1993) 2501-2506.]Search in Google Scholar
[A. Olsson, Y. Sheng, E. Kjellen and R. W. Pero, In vivo tumor measurement of DNA damage, DNA repair and NAD pools as indicators of radiosensitization by metoclopramide, Carcinogenesis 16 (1995) 1029-1035.10.1093/carcin/16.5.1029]Search in Google Scholar
[R. A. Harrington, C. W. Hamilton, R. N. Brogden, J. A. Linkewich, J. A. Romankiewicz and R. C. Heel, Metoclopramide: an updated review of its pharmacological properties and clinical use, Drugs 25 (1983) 451-494.]Search in Google Scholar
[D. M. Brahmankar and S. B. Jaiswal, Application of Pharmacokinetic Principles-Biopharmaceutics and Pharmacokinetics, 1st ed., Vallaph Prakashan, Delhi 1998, p. 311.]Search in Google Scholar
[H. C. Ansel, L. V. Allen and N. G. Popovich, Capsules and Tablets, in Pharmaceutical Dosage Forms and Drug Delivery Systems, 7th ed., Lippincott Williams & Wilkins, Philadelphia 2002, pp. 204-209.]Search in Google Scholar
[C. N. Patra, A. B. Kumar, H. K. Pandit, S. P. Singh and M. V. Devi, Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride, Acta Pharm. 57 (2007) 479-489; DOI: 10.2478/v10007-007-0038-010.2478/v10007-007-0038-0]Search in Google Scholar
[United States Pharmacopoeia 28, National Formulary 23, Asian Edition, USP Convention, Rockville (MD) 2005, p. 1277.]Search in Google Scholar
[Guidance for Industry, SUPAC-MR: Modified Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation, U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) September 1997, CMC 8, Rockville (MD) 1997, p. 32.]Search in Google Scholar
[P. Costa, J. Manuel and S. Labao, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1]Search in Google Scholar
[R. W. Korsmeyer, R. Gurny, E. Docler, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9]Search in Google Scholar
[N. A. Peppas, Analysis of Fickian and non Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.]Search in Google Scholar
[N. Adel, N. Fatma, A. Ismail, N. A. Boraie and L. M. Mortada, Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation, Drug. Dev. Ind. Pharm. 30 (2004) 985-993; DOI: 10.1081/DDC-200037245.10.1081/DDC-200037245]Search in Google Scholar
[J. Moore and H. Flanner, Mathematical comparison of dissolution profiles, Pharm. Tech. 20 (1996) 64-74.]Search in Google Scholar